ロード中...
Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST
BACKGROUND: In the Beta-Blocker Evaluation of Survival Trial (BEST) trial, systolic blood pressure (SBP) ≤120 mm Hg was an independent predictor of poor prognosis in ambulatory patients with chronic systolic heart failure (HF). Because SBP is an important predictor of response to beta-blocker therap...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3769783/ https://ncbi.nlm.nih.gov/pubmed/21982425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjca.2011.07.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|